Immunity against SARS-CoV-2 in the German population
Deutsches Ärzteblatt international · 2023
DOI: 10.3238/arztebl.m2023.0072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Deutsches Ärzteblatt international, 2023. Verfasst von Kai Schulze-Wundling und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Virology, University Hospital, Faculty of Medicine, Rhenish Friedrich Wilhelm University Bonn; German Center for Infection Research (DZI…. Hauptthemen laut MEDLINE: COVID-19, Cardiology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Early during the SARS-CoV-2 pandemic, national population-based seroprevalence surveys were conducted in some countries; however, this was not done in Germany. In particular, no seroprevalence surveys were planned for the summer of 2022. In the context of the IMMUNEBRIDGE project, the GUIDE study was carried out to estimate seroprevalence on the national and regional levels. METHODS: To obtain an overview of the population-wide immunity against SARS-CoV-2 among adults in Germany that would be as statistically robust as possible, serological tests were carried out using self-sampling dried blood spot cards in conjunction with surveys, one by telephone and one online. Blood samples were analyzed for the presence of antibodies to the S and N antigens of SARS-CoV-2. RESULTS: Among the 15 932 participants, antibodies to the S antigen were detected in 95.7%, and to the N antigen in 44.4%. In the higher-risk age groups of persons aged 65 and above and persons aged 80 and above, anti-S antibodies were found in 97,4% and 98.8%, respectively. Distinct regional differences in the distribution of anti-S and anti-N antibodies emerged. Immunity gaps were found both regionally and in particular subgroups of the population. High anti-N antibody levels were especially common in eastern German states, and high anti-S antibody levels in western German states. CONCLUSION: These findings indicate that a large percentage of the adult German population has formed antibodies against the SARS-CoV-2 virus. This will markedly lower the probability of an overburdening of the health care system by hospitalization and high occupancy of intensive care units due to future SARS-CoV-2 waves, depending on the viral characteristics of then prevailing variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Virology, University Hospital, Faculty of Medicine, Rhenish Friedrich Wilhelm University Bonn; German Center for Infection Research (DZIF), Locations: Bonn - Cologne, Hannover - Brunswick Medical Care Cente…
Zitieren
APA
Schulze-Wundling, K., Ottensmeyer, P. F., Meyer-Schlinkmann, K. M., Deckena, M., Krüger, S., Schlinkert, S., Budde, A., Münstermann, D., Töpfner, N., Petersmann, A., Nauck, M., Karch, A., Lange, B., Blaschke, S., Tiemann, C., & Streeck, H. (2023). Immunity against SARS-CoV-2 in the German population. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.m2023.0072
Vancouver
Schulze-Wundling K, Ottensmeyer PF, Meyer-Schlinkmann KM, Deckena M, Krüger S, Schlinkert S, et al. Immunity against SARS-CoV-2 in the German population. Deutsches Ärzteblatt international. 2023. doi:10.3238/arztebl.m2023.0072
BibTeX
@article{SchulzeWundling2023,
author = {Schulze-Wundling, Kai and Ottensmeyer, Patrick Frank and Meyer-Schlinkmann, Kristin Maria and Deckena, Marek and Krüger, Stefan and Schlinkert, Simon and Budde, Axel and Münstermann, Dieter and Töpfner, Nicole and Petersmann, Astrid and Nauck, Matthias and Karch, André and Lange, Berit and Blaschke, Sabine and Tiemann, Carsten and Streeck, Hendrik},
title = {Immunity against SARS-CoV-2 in the German population},
journal = {Deutsches Ärzteblatt international},
year = {2023},
doi = {10.3238/arztebl.m2023.0072}
}
EUVIMED